Stryker (NYSE:SYK) Operating Cash Flow per Share

: $7.91 (TTM As of Jun. 2023)

View and export this data going back to 1988. Start your Free Trial

Stryker's operating cash flow per share for the three months ended in Jun. 2023 was $1.79. Stryker's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2023 was $7.91.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Stryker was 13.40% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 6.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 10.90% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 7.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Stryker's Operating Cash Flow per Share or its related term are showing as below:

SYK' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -15.9 Med: 12.2 Max: 52.2
Current: 6

During the past 13 years, Stryker's highest 3-Year average Operating Cash Flow per Share Growth Rate was 52.20% per year. The lowest was -15.90% per year. And the median was 12.20% per year.

SYK's 3-Year OCF Growth Rate is ranked better than
52.23% of 672 companies
in the Medical Devices & Instruments industry
Industry Median: 4.70 vs SYK: 6.00

Stryker Operating Cash Flow per Share Historical Data

The historical data trend for Stryker's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Stryker Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Operating Cash Flow per Share

6.86

5.77

8.62

8.54

6.87

Stryker Quarterly Data
	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Operating Cash Flow per Share																1.38	2.33	2.62	1.16	1.79

Stryker Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Stryker's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (A: Dec. 2022 )	=	Cash Flow from Operations (A: Dec. 2022 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2022 )
	=	2624	/	382.200
	=	6.87

Stryker's Operating Cash Flow per Share for the quarter that ended in Dec. 2022 is calculated as

Operating Cash Flow per Share (Q: Jun. 2023 )	=	Cash Flow from Operations (Q: Jun. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Jun. 2023 )
	=	688	/	383.900
	=	1.79

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.91

Stryker Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Stryker's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Stryker (NYSE:SYK) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Stryker Corp (NYSE:SYK) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

SYK:Mexico SYK:Germany S1YK34:Brazil SYK:Austria

Address

2825 Airview Boulevard, Kalamazoo, MI, USA, 49002

Website

https://www.stryker.com

Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and spinal devices. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Just over one fourth of Stryker's total revenue currently comes from outside the United States.

Executives

James Andrew Pierce	officer: Group President	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Spencer S Stiles	officer: Group President	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Giovanni Caforio	director	BRISTOL-MYERS SQUIBB COMPANY, ROUTE 206 & PROVINCELINE ROAD, LAWRENCEVILLE NJ 08543
Skeete Tatum Lisa M	director	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Robert S Fletcher	officer: VP, Chief Legal Officer	2825 AIRVIEW BOULEVARD, KALAMAZOO MI 49002
Viju Menon	officer: Group President	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Sherilyn S Mccoy	director	JOHNSON & JOHNSON, ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK NJ 08933
Rajeev Suri	director	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Mary K Brainerd	director	8170 33RD AVENUE SOUTH, BLOOMINGTON MN 55425
Graham A Mclean	officer: President, Asia-Pacific	1 CORPORATE AVENUE ROWVILLE, VICTORIA C3 3178
Glenn S Boehnlein	officer: Vice President, CFO	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
M Kathryn Fink	officer: VP, Global Human Resources	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Yin C Becker	officer: VP, Comm. & Public Affairs	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Bijoy Sagar	officer: VP, Chief Information Officer	2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Michael Damon Hutchinson	officer: General Counsel	2825 AIRVIEW BLVD, KALAMAZOO MI 49002